250P Liver Toxicity (LT) in patients (pts) with ER-positive HER2-negative metastatic breast cancer (MBC) treated with first-line Cyclin-Dependent Kinase 4/6 inhibitors (CDKi)
Title:
250P Liver Toxicity (LT) in patients (pts) with ER-positive HER2-negative metastatic breast cancer (MBC) treated with first-line Cyclin-Dependent Kinase 4/6 inhibitors (CDKi)
Author:
Cano, K.S. Vega Mascaro, P. Mirallas, O. Filippi-Arriaga, F. Joval, L. Zamora, E. Gomez, L. Sanz Velez, C. Ortiz Lapena, M. Cruellas Arumi de Dios, M.A. Puy, M. Borrell Esteban, P. Ruiz-Ortega, L. Buch, P.B. YaringaƱo, J. Lores, G. Molina Gomez-Puerto, D. Manich, C. Saura Riveiro-Barciela, M. Bellet-Ezquerra, M.